Adaptive Biotechnologies Corp Cash Flow Statement

Cash Flow Statement Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -42.83M-46.45M-68.61M-146.23M-207.30M-200.37M-225.30M-159.59M
Depreciation and Depletion 4.10M4.30M6.10M6.80M12.30M19.22M20.53M17.60M
Share-based Compensation 7.01M11.15M13.12M24.76M43.25M55.48M62.91M53.61M
Gains from Sales and Divestitures 0.01M0.00M0.02M0.30M1.51M2.59M
Gains from Investment Securities 12.09M15.16M16.65M14.43M12.78M13.52M12.88M12.30M
Asset Writedowns and Impairment 0.19M0.02M25.43M7.21M
Non-cash Items 36.16M41.69M398.38M668.46M156.10M6.65M0.51M2.16M
Cash from Operations -34.86M-32.26M205.40M-149.68M-192.73M-183.94M-156.32M-95.21M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 1.69M1.70M4.46M1.70M-7.23M1.70M9.18M8.21M
Depreciation & Amortization (CF) 4.10M4.30M6.10M6.80M12.30M20.92M22.23M19.26M
Change in Working Capital
Change in Receivables 2.43M-0.78M7.82M-2.61M7.36M22.65M-2.03M3.74M
Change in Inventory 2.70M3.05M1.23M4.99M5.20M-0.82M2.84M-5.37M
Change in Accured Expenses -1.52M2.19M6.15M7.50M3.94M7.11M-5.41M0.67M
Other Working Capital Changes 2.53M-0.65M266.93M0.01M0.04M0.62M0.76M0.77M
Investing Activities
Capital Expenditures 2.42M6.30M11.20M18.80M61.75M16.35M10.70M3.66M
Sales of Property, Plant and Equipment 0.21M0.02M
Change in Intangibles 0.09M
Change in Acquisitions & Divestments 163.91M153.54M413.72M596.72M559.50M298.03M569.90M325.71M
Cash from Investing Activities 36.43M0.74M-481.70M-117.04M181.21M2.90M129.65M77.79M
Financing Activities
Other financing activities 0.09M-0.02M4.99M0.32M
Cash from Financing Activities 50.03M1.25M319.92M293.59M27.15M132.26M2.25M0.24M
Additional items
Change in Cash 51.61M-30.27M43.62M26.86M15.63M-48.77M-24.43M-17.18M
Beginning Cash Balance -51.61M85.31M52.95M96.58M123.44M138.81M89.50M65.10M
Free Cash Flow -37.28M-38.56M194.20M-168.49M-254.47M-200.29M-167.02M-98.88M
Net Cash Flow 51.61M-30.27M43.62M26.86M15.63M-48.77M-24.43M-17.18M